Ventyx Biosciences, Inc. (VTYX)
Mar 4, 2026 - VTYX was delisted (reason: acquired by LLY)
14.00
+0.02 (0.14%)
Inactive · Last trade price on Mar 3, 2026

Ventyx Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Cash & Equivalents
31.9727.2651.5864.8270.790.24
Short-Term Investments
160.67190.06200.64253.12187.79-
Cash & Short-Term Investments
192.64217.32252.22317.94258.580.24
Cash Growth
-29.90%-13.84%-20.67%22.96%105873.77%-
Other Current Assets
8.4612.312.1312.754.440
Total Current Assets
201.09229.63264.35330.69263.020.25
Net Property, Plant & Equipment
9.3810.2812.271.940.25-
Long-Term Investments
-35.62-38.6728.15-
Other Long-Term Assets
0.991.031.080.10.06-
Total Assets
211.47276.56277.69371.4291.480.25
Accounts Payable
0.993.135.766.434.661.1
Accrued Expenses
9.088.5915.519.517.620.3
Current Portion of Leases
1.181.0510.41--
Total Current Liabilities
11.2612.7822.2716.3612.281.4
Long-Term Leases
8.849.7411.511.15--
Other Long-Term Liabilities
-----29.5
Total Long-Term Liabilities
8.849.7411.511.15-29.5
Total Liabilities
20.122.5233.7717.5112.2830.9
Common Stock
0.010.01000.01-
Additional Paid-in Capital
822.7808.19663.15581.24397.051.85
Accumulated Other Comprehensive Income
0.220.16-0.05-1.12-0.06-
Retained Earnings
-631.57-554.31-419.19-226.23-117.8-32.5
Total Common Shareholders' Equity
191.36254.05243.92353.89279.2-30.65
Shareholders' Equity
191.36254.05243.92353.9279.2-30.65
Total Liabilities & Equity
211.47276.56277.69371.4291.480.25
Total Debt
10.0210.7912.511.5600
Net Cash (Debt)
182.61206.53239.71316.38258.580.24
Net Cash Growth
-11.58%-13.84%-24.23%22.36%105873.77%-
Net Cash Per Share
2.573.024.096.0320.160.12
Book Value
191.36254.05243.92353.89279.2-30.65
Book Value Per Share
2.693.714.176.7421.77-15.41
Tangible Book Value
191.36254.05243.92353.89279.2-30.65
Tangible Book Value Per Share
2.693.714.176.7421.77-15.41
Updated Nov 6, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q